INDIVIOR PHARMACEUTICALS INC (INDV)
Health Care · Specialty pharmaceuticals - addiction and pain management · NASDAQ
Indivior is a specialty pharmaceutical company focused on treating addiction and related disorders, with a primary product portfolio anchored by SUBLOCADE, a long-acting buprenorphine injection.
What INDIVIOR PHARMACEUTICALS INC does
Indivior Pharmaceuticals is a specialty pharmaceutical company that manufactures and distributes medications addressing addiction, pain, and other indications. The company relies heavily on SUBLOCADE, a long-acting buprenorphine injection, for a significant portion of its revenues. Indivior operates under stringent regulatory requirements as a manufacturer and distributor of controlled substances, and relies on third-party payors and government reimbursement programs for revenue generation. The company faces competition in the pharmaceutical industry while maintaining manufacturing facilities and managing complex supply chains.
Themes: ["Addiction and substance use disorder treatment","Opioid use disorder medications","Controlled substances manufacturing","Specialty pharmaceuticals"]
Fundamentals
- Price$41.30 as of 2026-07-09 close
- Market cap$5.0B as of 2026-07-10
- 1-year return+172.8% as of 2026-07-09 close
- P/E20.06 as of 2026-07-10
- Net margin+19.4% as of 2026-07-10
- Gross margin+81.3% as of 2026-07-10
- ROE+159.1% as of 2026-07-10
- Debt / equity27.90 as of 2026-07-10
- Revenue growth (YoY)+10.3% as of 2026-07-10
- Revenue CAGR (3y)+11.2% SEC XBRL
- Beta0.52 as of 2026-07-10
Key risks (from latest filing)
["Heavy revenue concentration in SUBLOCADE; slower-than-expected revenue growth or market adoption could materially harm business and profitability.","Leveraged balance sheet with long-term debt obligations; reduction in revenues may adversely affect liquidity and profitability.","Subject to stringent manufacturing practices, regulatory inspection, product liability claims, and risks related to distribution of controlled substances."]
Competitors & peers
- Purdue Pharma
- Reckitt Benckiser (RB)
- Opiant Pharmaceuticals
- Camurus
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.